Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Choosing zero based budgeting can significantly improve your financial awareness. Discover the reasons to adopt this method today.
22,496 articlesA cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Adobe faces a pivotal shift as its own AI tool accelerates cannibalization of the stock library, forcing a rethinking...
Eight senior researchers have left the Ethereum Foundation since January 2026, signaling a pivotal governance clash a...
As summer approaches, investors debate whether the market is primed for a rally or headed for a slump. This guide bre...
Groupon is charting a new path in local commerce as 2025 earnings loom. This guide breaks down the drivers, risks, an...
Palo Alto Networks is set to report fiscal Q3 after the close, with investors eyes on growth guidance and the CyberAr...
Dell Technologies shares have surged about 120% in a blistering run, pushing the stock toward record levels as AI inf...
XRP traded near the $0.60 mark as the broader crypto market declined, with Ripple expanding partnerships and pushing ...
AFL-CIO President Liz Shuler argues unions can power the AI era by pairing with business to train workers and shape t...
Netcapital announces a nonbinding LOI to buy Resmac’s mortgage assets from RezyFi in a $5 million all-stock transacti...
OpenAI moves to turn ChatGPT into a multi‑tool platform ahead of a likely IPO this year. The plan centers on a broad ...
SpaceX aims for a $1.75 trillion IPO, triggering a fierce debate among analysts about whether growth, cash flow, and ...